Welcome to our dedicated page for IACBU news (Ticker: IACBU), a resource for investors and traders seeking the latest updates and insights on IACBU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect IACBU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of IACBU's position in the market.
ION Acquisition Corp 2 Ltd. (NYSE: IACB.U, IACB, IACB WS) announced a special meeting on November 29, 2021, to approve its business combination with Innovid, Inc., a leading CTV advertising platform. The U.S. SEC has declared effective ION's Registration Statement on Form S-4 related to this merger. The closing of the business combination is contingent upon shareholder approval and standard closing conditions. The merger aims to enhance Innovid's advertising solutions and market position.
ION Acquisition Corp 2 Ltd. announced the pricing of its initial public offering of 22,000,000 units at $10.00 each, set to trade on the NYSE under the ticker symbol IACB.U starting February 11, 2021. Each unit consists of one Class A ordinary share and one-eighth of a redeemable warrant, which can be exercised at $11.50 per share. The offering is expected to close on February 16, 2021. The company aims to target business combinations with Israeli tech firms, sponsored by ION Holdings 2, LP, and is backed by Goldman Sachs & Co. LLC and Morgan Stanley.